08/12/2026
The numbers behind MeRT®:�
✅ 68% - More than two out of three participants no longer met the clinical criteria for PTSD following MeRT treatment.
✅ 52% - In the FDA-cleared clinical trial, people receiving MeRT experienced an average of 52% reduction in PTSD symptom severity.
These are results from the FDA-cleared clinical trial. Those receiving MeRT experienced clinically meaningful improvements in PTSD symptoms. This means that the participants experienced noticeable changes following MeRT treatment.
Curious about MeRT®? Call our New Patient Coordinator or visit our website to learn more.
📞(949) 506-4583
🌐braintreatmentnewportbeach.com
Results are from the FDA-cleared clinical trial evaluating the MeRT® System for the treatment of PTSD. Individual results may vary. MeRT® is FDA-cleared for the treatment of adults with PTSD.